| Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants LJ Abu-Raddad, H Chemaitelly, AA Butt New England Journal of Medicine 385 (2), 187-189, 2021 | 1083 | 2021 |
| Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021 | 850 | 2021 |
| Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 445 | 2022 |
| BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021 | 444 | 2021 |
| Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 404 | 2022 |
| mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ... Nature medicine 27 (9), 1614-1621, 2021 | 402 | 2021 |
| Seriously misleading results using inverse of Freeman‐Tukey double arcsine transformation in meta‐analysis of single proportions G Schwarzer, H Chemaitelly, LJ Abu‐Raddad, G Rücker Research synthesis methods 10 (3), 476-483, 2019 | 380 | 2019 |
| Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 361 | 2022 |
| Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting LJ Abu-Raddad, H Chemaitelly, JA Malek, AA Ahmed, YA Mohamoud, ... Clinical Infectious Diseases 73 (7), e1830-e1840, 2021 | 239 | 2021 |
| Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 219 | 2022 |
| Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions SP Kouyoumjian, H Chemaitelly, LJ Abu-Raddad Scientific reports 8 (1), 1661, 2018 | 192 | 2018 |
| SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ... EClinicalMedicine 35, 2021 | 188 | 2021 |
| Severity of SARS-CoV-2 reinfections as compared with primary infections LJ Abu-Raddad, H Chemaitelly, R Bertollini New England Journal of Medicine 385 (26), 2487-2489, 2021 | 178 | 2021 |
| Argileh smoking among university students: a new tobacco epidemic M Chaaya, ZE Roueiheb, H Chemaitelly, G Azar, J Nasr, B Al-Sahab Nicotine & tobacco research 6 (3), 457-463, 2004 | 156 | 2004 |
| Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, HM Yassine, FM Benslimane, ... Jama 326 (19), 1930-1939, 2021 | 149 | 2021 |
| Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic LJ Abu-Raddad, H Chemaitelly, HH Ayoub, Z Al Kanaani, A Al Khal, ... Scientific reports 11 (1), 6233, 2021 | 137 | 2021 |
| National Study Group for COVID-19 Vaccination LJ Abu-Raddad, H Chemaitelly, AA Butt Effectiveness of the BNT162b2 Covid-19 Vaccine against the B 1 (7), 187-9, 2021 | 135 | 2021 |
| Coronavirus disease 2019 disease severity in children infected with the omicron variant AA Butt, SR Dargham, S Loka, RM Shaik, H Chemaitelly, P Tang, ... Clinical Infectious Diseases 75 (1), e361-e367, 2022 | 133 | 2022 |
| Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa H Chemaitelly, I Cremin, J Shelton, TB Hallett, LJ Abu-Raddad Sexually transmitted infections 88 (1), 51-57, 2012 | 121 | 2012 |
| Protective effect of previous SARS-CoV-2 infection against Omicron BA. 4 and BA. 5 subvariants HN Altarawneh, H Chemaitelly, HH Ayoub, MR Hasan, P Coyle, ... New England Journal of Medicine 387 (17), 1620-1622, 2022 | 110 | 2022 |
Laith J. Abu-RaddadProfessor of Healthcare Policy and Research, Weill Cornell Medical College – QatarVerified email at qatar-med.cornell.edu
